Eric Ashley Adams

Eric Ashley Adams is a declared insider of InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,), with filings sourced from SEDI. We count 7 filings; the first trade dates from 16 June 2016 and the latest from 20 September 2016.

In open-market terms, that means 1 purchase worth €4,531 on one side and 4 sales worth €18k on the other. On balance, insiders were net sellers of €14k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant.

The record was last updated on 4 October 2016 with an open-market sale (€898) in InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,). The clock since the last published purchase (17 August 2016) now reads 3,723 days. Filings reach the SEDI feed a median of 14 days after the trade. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEDI. Past trades are no guide to future returns.